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Objective: To assess correlates of hepatitis B among adults with mental illness under care in Brazil.
Method: Cross-sectional national multicenter study of 2206 patients with mental illnesses randomly selected
from 26 public mental health services. Sociodemographic and behavioral data were obtained from face-to-
face interviews and psychiatric diagnoses from medical charts. Serology testing was conducted, and
prevalence rate ratios were estimated by log-binomial regression.
Results: The weighted prevalence rates of current hepatitis B virus (HBV) infection (HBsAg+) and previous
HBV exposure (anti-HBc+) were 2.0% [95% confidence interval (CI): 1.5%–2.7%] and 17.1% (95% CI: 16.0%–
19.0%), respectively. Correlates of HBsAg+ included male gender, younger age (18–29 years), unstable place
of residence, intellectual disability, main psychiatric diagnosis of dementia, presence of other medical
comorbitidy, use of alcohol/drugs during sex, more than one sexual partner and use of cocaine. Correlates of
anti-HBc+ included male gender, older age (≥30 years), black skin color, lower education, unstable place of
residence, currently hospitalized, intellectual disability, history of any sexually transmitted disease or syphilis,
poor HIV knowledge, history of imprisonment and sexual violence.
Conclusions: Hepatitis B is an important comorbidity among psychiatric patients in Brazil. Screening for HBV,
effective prevention and intervention strategies, including universal HBV immunization, should be routine
practices in these mental health services.
© 2014 Elsevier Inc. All rights reserved.1. Introduction
Hepatitis B virus (HBV) infection is a major cause of morbidity and
mortality worldwide and a serious public health problem. The World
Health Organization currently estimates that 2 billion people have
been infected with HBV, with more than 240 million living with
lifelong chronic infection [1]. Hepatitis B is often neglected because of
its largely asymptomatic course with long-term complications such as
cirrhosis of the liver and liver cancer. Approximately one third of all
cases of cirrhosis and half of all cases of hepatocellular carcinoma can
be attributed to chronic hepatitis B (CHB) [2]. An estimated 600,000
people worldwide die every year due to the acute or chronic
consequences of hepatitis B [1]. A vaccine against hepatitis B has
been available since 1982. It is 95% effective in preventing infection
and its chronic consequences, and it was the first vaccine against aelo Horizonte, MG 30150-260,
armo).major human cancer [1]. In Brazil, it has been available for universal
immunization at birth since 1992 in selected regions (e.g., Amazon
State) and nationwide since 1998.
HBV can be transmitted vertically from infected mothers to their
offspring, horizontally (e.g., child-to-child transmission within a
household), sexually or parenterally (e.g., via injecting drug use or
unsafe injections, sharps injury or contaminated blood products) [3].
HBV and HIV share common modes of transmission, especially
injecting drug use and unprotected sex [4].
Prevalence rates of CHB are associated with differences in the age
of acquisition of the virus. In areas of high endemicity, that is,
seroprevalence of hepatitis B surface antigen (HBsAg) greater than or
equal to 8.0%, as in China, Indonesia, Africa and Western Amazon
Region, lifetime risk of HBV infection is 60% and most infections are
acquired perinatally or in early infancy via child-to-child transmis-
sion. Early infection in life is associated with the highest risk for
development of chronic infection — children do not mount an
effective immune response to infection, particularly if their mothers
are positive for hepatitis B e antigen. In areas of low prevalence, that is,
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Europe, lifetime risk of HBV infection is less than 20% and most
infections occur via percutaneous or sexual transmission in adults,
particularly among health care workers, injecting drug users and men
who have sex with men. Transmission of HBV among adults is more
often associated with symptomatic acute HBV and an effective
immune response, resulting in clearance of the virus — only 2% to
5% of adult HBV infections develop into CHB [2,5].
Brazil is considered a country of intermediate seroprevalence, that
is, HBsAg between 2.0% and 7.0% [2]. However, the Western Amazon
basin, including Brazil and Peru, is a highly endemic area, with
observed HBsAg seroprevalence rates greater than 10.0% [6]. A recent
Brazilian population-based survey carried out in the urban population
between 2005 and 2009 estimated that 11.6% of the population ages
between 20 and 69 years had prior exposure to HBV, defined as
reactive hepatitis B core antibody (anti-HBc positive) and 0.6% had
current HBV infection (HBsAg positive) [7].
Reports indicate that patients with mental illnesses have a high
prevalence of HBV infection [4,8–16]. A systematic review of the
published literature showed that the prevalence of HBV infection
(prior exposure or current infection) among patients with chronic
mental illnesses varied from 3.2% to 66.0% [17]. This high HBV
prevalence could be partially explained by the fact that people with
mental illness appear to have increased rates of sexually transmitted
diseases (STDs) and are more likely to engage in high-risk behaviors
such as injection drug use, multiple sexual partners and high-risk
partners, unprotected sex, same-sex sexual activity, exchange of sex
for money or drugs and sex while using psychoactive substances
[18–21].
Although several studies have been conducted on hepatitis B
among psychiatric patients, few studies were carried out among this
population in low- and middle-income countries, especially with a
large and representative sample of patients. We have previously
reported point seroprevalence rates of previous exposure to HBV
(reactive anti-HBc) and current HBV infection (reactive HBsAg) of
14.7% and 1.64%, respectively, in a national representative sample of
psychiatric patients in Brazil [16]. These rates were significantly
higher compared to the general Brazilian population, with an
estimated prevalence of 7.4% for anti-HBc (previous exposure) and
0.37% for HBsAg (current infection) [7], and other specific Brazilian
populations, such as pregnant women (HBsAg=0.3%) [22] and blood
donors (anti-HBc-total=4.6%; HBsAg=0.35%) [23]. Furthermore,
there are also limited data on the assessment of factors associated
with HBV infection, especially with a large representative sample of
patients with mental illness on a national scale.
The aim of this study was to move beyond simply documenting
these high rates of HBV infection to ascertain the association of
sociodemographic, clinical and behavioral factors with HBV infection
(previous exposure to HBV or current HBV infection) among Brazilian
adults under public hospital or outpatient care for mental illness.
2. Methods
This analysis is part of a larger cross-sectional national multicenter
study in 11 public psychiatric hospitals and 15 public mental health
outpatient clinics (psychosocial care center [CAPS]) in Brazil, designed
to assess risk behavior and the seroprevalence of HIV and others STDs,
including HBV infection, among patients with mental illness (PES-
SOAS Project), between June and September 2006, as described in
detail elsewhere [16,24].
A two-stage probability sampling was used proportionally to the
type of care (hospital or outpatient care center [CAPS]) and the
distribution of reported AIDS cases according to the five Brazilian
Regions, yielding a total of 2475 participants. In the first stage, mental
health services were randomly selected proportionally to the number
of beds in the hospital stratum or number of registered patients in theCAPS stratum in each region. The second sampling stage was carried
out by selecting patients using simple random probability process at
each site. Eligibility criteria included adult (18 years or older)
psychiatric patients receiving care either at hospitals or adult CAPS.
Only patients who were considered capable of providing written
informed consent and who understood the aims of the study were
included in the study. This assessment was based on a preliminary
evaluation adapted from the Mini-Mental Status Examination
(MMSE), and it was applied by trained mental health professionals
(brief-MMSE) [25]. Public mental health outpatient clinics that
exclusively treated substance use disorders (CAPS-Ad) as primary
diagnoses were also excluded in order to avoid overestimating
prevalence rates. For this paper, a cross-sectional analysis was
conducted to examine correlates of HBV infection, and only patients
with both interview data and serology results for HBV infection were
included in this analysis (n=2206). Protocol, questionnaires and
procedures were tested in a pilot study and have been previously
described [24]. A semistructured person-to-person interview was
conducted to obtain sociodemographic, clinical and behavioral data. A
survey was developed to ascertain organizational attributes of
treatment settings. All interviews were carried out by experienced
mental health care professionals. The study was approved by the
Research Ethics Committee from the Federal University of Minas
Gerais (UFMG/ETIC 125/03) and the Brazilian National Review Board
(CONEP 592/2006).
2.1. Exposure and event measurements
The event of interest, infection of hepatitis B, was assessed in two
ways: previous exposure to HBV infection, represented as reactive
total anti-HBc and current HBV infection, represented as reactive
HBsAg. Blood samples for serology were collected using standard
procedures, including pretest counseling, and processed and checked
for quality control [16]. Blood testing for HBV was conducted using
standardmarkers for hepatitis B: HBsAg (ELISA, BioMerieux) and total
(IgG + IgM) anti-HBc (ELISA, BioMerieux). Results were returned to
patients in each participating site by research staff members. Patients
who were positive were referred for medical care and follow-up.
Potential explanatory characteristics investigated included the
following: (1) sociodemographic information (e.g., gender, age, skin
color, marital status, schooling, family income, place of residence,
history of homelessness or imprisonment), (2) clinical and psychiatric
conditions (e.g., type of center of recruitment, previous psychiatric
hospitalization, main psychiatric diagnoses, any degree of intellectual
disability, history of transfusion, history of any STD, previous HIV
testing and any medical comorbidity), and (3) behavioral variables
(history of injection drug use, alcohol or tobacco use, age of first
sexual intercourse, number of lifetime sexual partners, lifetime unsafe
sex, alcohol/drug use during sexual intercourse, money/drug ex-
change for sex, physical and sexual violence, self-perceived HIV risk
and HIV/AIDS knowledge). HIV/AIDS knowledge was assessed based
on a mean score of 10 questions rated on a 0 to 10 scale. Self-
perception of HIV risk was how the participants assessed their risk of
becoming HIV infected (low, did not know or high). Psychiatric
diagnoses were ascertained by psychiatrists and were obtained from
medical charts. When more than one psychiatric diagnosis were
present, these were recorded hierarchically according to clinical
severity as follows: (1) schizophrenia and other psychotic disorders,
(2) bipolar disorder, (3) depression with psychotic symptoms (DSP),
(4) depression, (5) anxiety, (6) substance use disorder, and (7) others,
according to the International Classification of Diseases, 10th Revision.
For this analysis, categories (1), (2) and (3) were grouped together as
severe mental illness (SMI), and the remaining diagnoses were
categorized as non-SMI. Dementia was considered a separate
category. Current place of residence was defined as unstable (living
in shelters, hostels, streets, rooms) and stable (living in houses or
400 R.A. Carmo et al. / General Hospital Psychiatry 36 (2014) 398–405apartments), and unsafe sex was defined as not always using
condoms. Reliability of the interview was considered adequate for
most variables as previously published [24].
2.2. Statistical analysis
A descriptive analysis was carried out, and Pearson chi-square test
was performed for the analysis of categorical data. The prevalence of
previous exposure to HBV infection and current HBV infection were
estimated by dividing the number of participants who were,
respectively, positive for anti-HBc or HBsAg markers, by the total
number of participants. The magnitude of the associations between
putative risk factors and each HBV infection marker was given by the
weighted prevalence ratio (PRw) with 95% confidence intervals (CIs)
using log-binomial regression for both univariate and multivariate
analyses. Estimates were proportionally weighted by the sample size
of each site relative to its total population, that is, number of beds or
number of registered patients, considering the potential within-
cluster correlation. The level of significance was .05. All variables with
P-values equal to or less than .20 obtained in the univariate analysis
were used to start multivariate modeling. A backward deletion
strategy was applied, and those variables with P-values equal to or
less than .05 remained in the final regressionmodel. All analyses were
carried out using SAS.
3. Results
Of the 3255 patients recruited during the study, 2475 were
interviewed and, for this analysis, 2206 had both interview data and
HBV serology available. No statistical differences were observed
between participants and nonparticipants with regard to age, sex and
type of care. Among the 2206 participants, 45 (2%; 95% CI: 1.5%–2.7%)
and 378 (17.1%; 95% CI: 16.0%– 19.0%) tested positive for HBsAg and
anti-HBc, respectively.
Descriptive data can be seen in Table 1. The majority of
participants were female (52.0%), were older than 30 years (81.8%),
were single (66.5%), had less than 5 years of schooling (50.3%), had
low monthly family income (bUS$ 210) (53.7%), and lived in a stable
place of residence (87.8%). Eighteen percent had a history of
homelessness, and most participants were recruited from outpatient
centers (CAPS) (64.4%). History of psychiatric hospitalization was
reported by 58.0%, and 31.2% had some degree of intellectual disability
symptoms. SMI accounted for most psychiatric diagnoses (56.5%),
followed by non-SMI (36.5%) and dementia (7.0%). Other medical
comorbidity was reported by 45.2% of individuals.
Previous STDs were reported by 24.0% of participants. Despite a
high percentage of high-risk behavior among this population,
including age of first sexual intercourse less than 18 years (57.3%),
use of alcohol and drugs during sex (27.3%), more than one sexual
partner in lifetime (65.5%) and unsafe sex (80.8%), more than 73.0%
had never tested for HIV infection before. Also, 45.2% had poor HIV
knowledge, and only 17.9% perceived themselves in a high-risk
situation for HIV acquisition. Although 24.7% of this population
reported the use of any illicit drug, including cannabis use (21.4%) and
inhaled cocaine use (10.4%), the proportion of lifetime injection drug
use was low (2.9%). Moreover, tobacco and alcohol use were reported
by 71.3% and 64.0%, respectively. History of imprisonment was
reported by 25.3%, and physical violence and sexual violence were
described by 58.0% and 20.0%, respectively.
3.1. Univariate analysis
Univariate analyses for both HBV markers can be seen in Table 2.
For most variables, statistical significance and direction of the
prevalence rate ratio were similar for both markers. Among socio-
demographics, male gender, black skin color, single marital status,unstable place of residence, history of homelessness, study recruit-
ment in hospital, symptoms of intellectual disability, main diagnosis
of dementia, history of syphilis, poor HIV/AIDS knowledge, low/don't
know self-perceived risk of HIV, history of imprisonment, cocaine use
in lifetime, alcohol use in lifetime and report of physical violence were
statistically associated with both serologic markers for hepatitis B:
HBsAg (current HBV infection) and anti-HBc (previous exposure to
HBV infection).
In addition, less than 5 years of schooling, low family income,
previous psychiatric hospitalization, history of any STD, younger age
of first sexual intercourse (b18 years), money/drugs exchange for sex,
tobacco use in lifetime, unsafe sex and report of sexual violence were
also statistically associated with previous exposure to HBV (positive
anti-HBc) in this population. We should note an opposite direction of
the association for the variable age: younger age (18–29 years) was
associated with a positive HBsAg, while older age (more than 30
years) was associated with a positive anti-HBc.
3.2. Multivariate analysis
The following variables showed a statistically independent
association with a positive HBsAg: male gender, younger age (18–
29 years), unstable place of residence, symptoms of intellectual
disability, main psychiatric diagnosis of dementia, presence of other
medical comorbidity, use of alcohol/drugs during sex, more than one
sexual partner and use of cocaine in lifetime. On the other hand, male
gender, older age (≥30 years), black skin color, less than 5 years of
schooling, unstable place of residence, study recruitment in hospital,
symptoms of intellectual disability, history of any STD, history of
syphilis, poor HIV knowledge, history of imprisonment and the report
of sexual violence were found to be independently associated with a
positive anti-HBc (Table 3).
4. Discussion
The present study is the first known national representative study
to assess potential factors associated with HBV infection among adults
under public hospital or outpatient care for mental illness in Brazil.
We were able to demonstrate that while HBV infection occurs at an
elevated rate among people with mental illness, HBV infection is not
uniformly distributed in this population but rather is linked to specific
sociodemographic characteristics, comorbidities and risk behaviors.
As in our previous study, we found that psychiatric patients had
much higher rates of exposure to HBV than the general Brazilian
population, with 17.1% of the psychiatric patients in this survey
having been previously exposed to HBV infection (represented as
reactive anti-HBc) compared with 7.4% of the general Brazilian
population (11.6% when stratified for age between 20 and 69 years)
[7]. Current HBV infection (reactive HBsAg) at time of the survey was
found in 2.0% of psychiatric patients compared with 0.37% (0.6%
between 20 and 69 years old) in the general Brazilian population [7].
Our frequencies were similar to those found among psychiatric
populations in Taiwan [26], the United States [4], and India [19],
corroborating studies indicating that patientswithmental illness have
a higher risk for hepatitis B infection [4,10,14,15,17].
Considering that HBsAg is a marker of current infection, that it is
present in acute HBV infection, and that acute hepatitis B resolves
spontaneously in more than 90% of adults, we hypothesize that some
patients with reactive HBsAg could be in the acute phase of the
infection and might subsequently clear the infection. We cannot
comment on this further due to the cross-sectional nature of our study
and the lack of testing for the IgM anti-HBc marker to confirm acute
hepatitis B infection.
With regard to sociodemographic characteristics, age showed a
distinct pattern between the two markers in our study: younger age
(18–29 years) was associated with current infection (HBsAg), while
Table 1
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Age of first sexual sex (y)a
≥18 794 (42.7)
b18 1063 (57.3)
Alcohol/drug use during sex
No 1592 (72.7)
Yes 599 (27.3)
Money/Drugs exchange for sex
No 1615 (73.6)
Yes 578 (26.4)
Number of sexual partners
More than one 1362 (65.5)
Only one or none 719 (34.6)
HIV knowledge
Good 1198 (54.8)
Low/Did not know 987 (45.2)
Self-perceived risk of HIV
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Table 1 (continued)
Characteristics n (%)
Inhaled cocaine use (ever)
No 1970 (89.6)
Yes 230 (10.4)
























a Among those sexually active ever.
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to HBV infection (anti-HBc). A possible explanation for this finding is
that age is a marker for longer exposure and thus a higher probability
of acquiring HBV infection. Additionally, universal immunization
beginning at birth and other successful hepatitis B vaccination
strategies of the Brazilian Ministry of Health since 1992 have resulted
in a dramatic reduction of vertical HBV transmission. However, in this
century, it is estimated that 25% of the population younger than 20
years in Brazil has not been vaccinated against HBV [27].
Sexual and household transmission of HBV remains a concern
among unvaccinated adolescents and adults. HBV is efficiently
transmitted sexually, and sexual contacts of chronically infected
persons have been shown to have a higher seroprevalence of HBV
infection than control populations, as have nonsexual household
contacts of infected persons. People with acute hepatitis B are more
likely to report multiple heterosexual partners than controls, and the
seroprevalence of HBV infection correlates with greater numbers of
recent and lifetime heterosexual partners [2]. Men who have sex with
men have persistently higher HBV seroprevalence rates than the
general population [2].
Sexual transmission of HBV is certainly of concern among
psychiatric populations where patterns of unsafe sexual behaviors
have been repeatedly documented. In this study, the majority of our
participants had more than one lifetime sexual partner, had a history
of unsafe sex with low self-perceived risk of HIV infection and had not
been tested for HIV. Our analyses indicated that hepatitis B was
consistently associated with sexual risk behaviors such as alcohol/
drug use during sex andmore than one sexual partner for current HBV
infection (reactive HBsAg), while a history of any STD or syphilis was
associated with previous exposure to HBV (reactive anti-HBc).
Moreover, sexual violence was significantly associated with previous
exposure to HBV infection. Such associations of hepatitis B and sexual
risks are consistent with prior research among persons with mental
illness [4,28,29]. A history of cocaine use was also a predictor of HBV
infection (current infection — HBsAg) in our study, and this
association is corroborated by other authors [4,10,29].
With regard to gender, our results are consistent with other
studies conducted among persons with mental illness [14,19,30] in
finding higher rates among men of both current infection (HBsAg)
Table 2
Univariate analysis of HBsAg and total anti-HBc seroprevalence, PESSOAS Project 2006–2007 (n=2206)
Characteristics Na HBsAg Total anti-HBc
n (%)b (Wt%)c PRR (95% CI)d χ2 (P-value) n (%)2 (Wt%)c PRR (95% CI)d χ2 (P-value)
Gender
Female 1147 13 (1.13) (1.51) 1.00 148 (12.90) (15.39) 1.00
Male 1059 32 (3.02) (4.66) 3.09 (2.23–4.25) 46.80⁎⁎ 230 (21.72) (32.00) 2.08 (1.89–2.29) 222.70⁎⁎
Age (y)
≥30 1804 34 (1.88) (2.80) 1.00 348 (19.29) (26.51) 2.27 (1.91–2.70)
18–29 402 11 (2.74) (5.18) 1.85 (1.32–2.44) 15.80⁎⁎ 30 (7.46) (11.67) 1.00 86.10⁎⁎
Skin color
Others 1848 33 (1.79) (2.83) 1.00 298 (16.13) (22.27) 1.00
Black 358 12 (3.35) (5.07) 1.79 (1.32–2.44) 13.80⁎⁎ 80 (22.35) (34.36) 1.54 (1.40–1.70) 74.20⁎⁎
Marital status
Married/in union 739 12 (1.62) (1.67) 1.00 109 (14.81) (20.15) 1.00
Single 1467 33 (2.25) (3.75) 2.25 (1.53–3.30) 17.10⁎⁎ 269 (18.30) (25.66) 1.27 (1.15–1.41) 20.70⁎⁎
Schooling (y)
≥5 1097 22 (2.01) (2.71) 1.00 140 (12.76) (18.65) 1.00
b5 1109 23 (2.07) (3.54) 1.30 (0.98–1.72) 3.50 238 (21.46) (28.49) 1.53 (1.39–1.68) 81.30⁎⁎
Family income
≥US$ 210 969 17 (1.75) (2.36) 1.00 119 (12.34) (15.89) 1.00
bUS$ 210 1124 24 (2.14) (3.21) 1.36 (0.99–1.87) 3.63 231 (20.52) (28.15) 1.77 (1.59–1.97) 107.80⁎⁎
Place of residence
Stable 1937 29 (1.50) (1.68) 1.00 284 (14.66) (17.03) 1.00
Unstable 269 16 (5.95) (6.37) 3.78 (2.86–5.00) 87.60⁎⁎ 94 (34.94) (39.62) 2.33 (2.14–2.53) 388.20 ⁎⁎
History of homelessness
No 1810 28 (1.55) (2.35) 1.00 283 (15.61) (22.46) 1.00
Yes 396 17 (4.29) (6.21) 2.64 (2.02–3.46) 49.70⁎⁎ 95 (24.17) (30.58) 1.36 (1.24–1.50) 40.60⁎⁎
Type of center of recruitment
Outpatient (CAPS) 1421 24 (1.69) (1.60) 1.00 197 (13.92) (13.94) 1.00
Hospital 785 21 (2.68) (4.38) 2.73 (1.97–3.78) 36.50⁎⁎ 181 (22.88) (31.92) 2.29 (2.07–2.54) 247.70⁎⁎
Previous psychiatric hospitalization
No 922 16 (1.74) (2.84) 1.00 120 (13.04) (21.45) 1.00
Yes 1276 29 (2.27) (3.44) 1.21 (0.92–1.61) 1.83 256 (20.03) (26.19) 1.22 (1.12–1.34) 18.60⁎⁎
Intellectual disability (any degree)
No 1509 25 (1.66) (2.03) 1.00 200 (13.24) (18.42) 1.00
Yes 685 19 (2.77) (4.64) 2.28 (1.73–3.02) 33.50⁎⁎ 176 (25.77) (33.01) 1.79 (1.64–1.95) 176.60⁎⁎
Main psychiatric diagnosis
SUD, anxiety, depression, others 805 11 (1.37) (2.54) 1.00 125 (15.63) (20.89) 1.00
Psychosis/Bipolar disorder/DSP 1246 28 (2.25) (2.70) 1.27 (0.88–1.82) 1.70 216 (17.27) (24.41) 1.16 (1.05–1.29) 7.80⁎⁎
Dementia 155 6 (3.87) (7.18) 3.43 (2.30–5.14) 36.20 ⁎⁎ 37 (23.87) (31.11) 1.42 (1.23–1.64) 22.60⁎⁎
Medical comorbidity
No 1199 19 (1.58) (2.51) 1.00 209 (17.4) (24.8) 1.00
Yes 990 26 (2.63) (4.14) 1.64 (1.25–2.16) 12.70 ⁎⁎ 164 (16.6) (22.9) 0.92 (0.83–1.02) 2.32
History of any STD
No 1655 34 (2.05) (3.26) 1.00 259 (15.67) (22.69) 1.00
Yes 521 10 (1.92) (3.01) 0.93 (0.66–1.30) 0.21 112 (21.37) (28.32) 1.25 (1.33–1.38) 19.30⁎⁎
History of syphilis
No 2068 40 (1.93) (3.03) 1.00 336 (16.24) (23.05) 1.00
Yes 72 3 (4.17) (7.13) 2.36 (1.36–4.07) 9.40 ⁎⁎ 21 (29.17) (40.93) 1.78 (1.48–2.13) 38.00⁎⁎
Previous HIV testing
No 1608 29 (1.80) (3.18) 1.00 271 (16.81) (23.84) 1.00
Yes 598 16 (2.68) (3.15) 0.99 (0.73–1.35) 0.00 107 (18.01) (25.01) 1.05 (0.95–1.16) 0.90
Age of first sexual intercourse (y)e
≥18 794 15 (1.89) (2.55) 1.00 114 (14.34) (18.32) 1.00
b18 1063 20 (1.88) (2.31) 0.91 (0.64–1.29) 0.30 178 (16.86) (22.96) 1.25 (1.12–1.40) 15.80⁎⁎
Alcohol/Drug use during sex
No 1592 27 (1.70) (2.39) 1.00 261 (16.42) (23.48) 1.00
Yes 599 18 (3.01) (5.67) 2.37 (1.81–3.10) 39.80⁎⁎ 113 (18.80) (24.57) 1.05 (0.95–1.16) 0.80
Money/Drugs exchange for sex
No 1615 31 (1.92) (3.10) 1.00 264 (16.36) (22.82) 1.00
Yes 578 14 (2.42) (3.46) 1.12 (0.83–1.49) 0.55 113 (19.52) (27.16) 1.19 (1.09–1.30) 13.70⁎⁎
Number of sexual partners
Only one or none 719 10 (1.39) (1.98) 1.00 116 (16.13) (24.16) 1.00
More than one 1362 30 (2.20) (3.66) 1.85 (1.33–2.59) 13.10⁎⁎ 236 (17.33) (23.34) 0.97 (0.88–1.06) 0.52
HIV knowledge
Good 1198 20 (1.67) (2.61) 1.00 147 (12.33) (16.29) 1.00
Low/Did not know 987 25 (2.53) (3.76) 1.44 (1.09–1.91) 6.60⁎⁎ 223 (22.43) (29.65) 1.82 (1.65–2.00) 176.60⁎⁎
Self-perceived risk of HIV
High 396 7 (1.77) (1.34) 1.00 71 (17.93) (21.16) 1.00
Low/Did not know 1810 38 (2.10) (3.50) 2.60 (1.50–4.52) 11.60⁎⁎ 307 (16.96) (24.68) 1.67 (1.03–1.33) 5.50⁎
History of imprisonment
No 1647 29 (1.76) (2.44) 1.00 230 (14.01) (18.69) 1.00
Yes 559 16 (2.86) (5.01) 2.06 (1.57–2.69) 27.80⁎⁎ 148 (26.24) (37.53) 2.01 (1.85–2.18) 266.40⁎⁎
Any illicit drug use (ever)
No 1661 31 (1.87) (2.85) 1.00 275 (16.57) (24.17) 1.00
Yes 545 14 (2.57) (4.28) 1.50 (1.12–2.01) 7.51⁎⁎ 103 (18.86) (24.06) 0.99 (0.90–1.10) 0.01
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Table 2 (continued)
Characteristics Na HBsAg Total anti-HBc
n (%)b (Wt%)c PRR (95% CI)d χ2 (P-value) n (%)2 (Wt%)c PRR (95% CI)d χ2 (P-value)
Cannabis use (ever)
No 1729 32 (1.85) (2.80) 1.00 286 (16.54) (24.00) 1.00
Yes 472 13 (2.75) (4.75) 1.69 (1.26–2.27) 12.50⁎⁎ 90 (19.07) (24.62) 1.02 (0.92–1.14) 0.22
Cocaine use (ever)
No 1970 34 (1.73) (2.67) 1.00 328 (16.64) (23.72) 1.00
Yes 230 11 (4.78) (8.13) 3.04 (2.24–4.14) 50.40⁎⁎ 48 (20.96) (27.97) 1.18 (1.03–1.35) 5.70⁎
Injection drug use (ever)
No 2130 43 (2.02) (3.05) 1.00 359 (16.85) (23.84) 1.00
Yes 64 2 (3.13) (7.46) 2.44 (1.54–3.89) 14.30⁎⁎ 15 (23.44) (27.64) 1.16 (0.94–1.43) 1.93
Tobacco use (ever)
No 629 9 (1.43) (2.69) 1.00 83 (13.20) (18.03) 1.00
Yes 1566 36 (2.30) (3.35) 1.24 (0.89–1.74) 1.68 293 (18.71) (26.09) 1.45 (1.29–1.62) 39.40⁎⁎
Alcohol use (ever)
No 794 12 (1.51) (1.39) 1.00 131 (16.56) (22.66) 1.00
Yes 1412 33 (2.34) (4.27) 3.08 (2.14–4.22) 36.90⁎⁎ 247 (17.46) (25.04) 1.10 (1.00–1.21) 4.70⁎
Physical violence
No 925 16 (1.73) (2.42) 1.00 140 (15.18) (22.13) 1.00
Yes 1276 29 (2.27) (3.75) 1.55 (1.16–2.07) 8.87⁎ 237 (18.54) (25.75) 1.16 (1.06–1.27) 11.10⁎⁎
Sexual violence
No 1757 34 (1.94) (3.08) 1.00 286 (16.23) (22.81) 1.00
Yes 442 11 (2.49) (3.65) 1.18 (0.86–1.62) 1.11 89 (20.37) (28.37) 1.24 (1.13–1.37) 18.60⁎⁎
Lifetime unsafe sex
No 417 9 (2.16) (3.25) 1.00 79 (18.76) (27.68) 1.00
Yes 1758 35 (1.99) (3.07) 0.94 (0.68–1.30) 0.13 293 (16.70) (22.85) 0.82 (0.75–0.91) 14.92⁎⁎
⁎ Pb .05.
⁎⁎ Pb .01.
a N=total number of participants in each category.
b n (%)=number and unweighted proportion of positives in each category.
c Wt%=weighted proportion of positives in each category.
d PRR=prevalence rate ratio (weighted prevalence rate ratio).
e Among those sexually active.
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social contextual factors that are more common among men such as
homelessness, unstable residence, imprisonment and drug use, each of
which was associated with reactive HBsAg and anti-HBc in our study.
The association between HBV infection and indicators of low social
class is quite strong. In the general population, socioeconomic factors
such as low educational attainment, lower social stratum and
crowded urban residence have been reported to predict higher HBVTable 3
Final multivariate analysis of HBsAg and total anti-HBc seroprevalence, PESSOAS Project 20
Characteristics HBsAg
PRR (95% CI)a




Skin color (black) –
Schooling (y) (b5) –
Place of residence (unstable) 3.38 (2.43–4.69)
Type of center (hospital) –
Intellectual disability (any degree) 2.06 (1.53–2.78)
Main psychiatric diagnosis
SUD, anxiety, depression, others 1.0
Psychosis/Bipolar disorder/DSP 0.81 (0.57–1.66)
Dementia 1.66 (1.09–2.54)
Medical comorbidity (yes) 1.66 (1.24–2.21)
History of any STD (yes) –
History of syphilis (yes) –
Alcohol/drug use during sex (yes) 1.43 (1.01–2.03)
Number of sexual partners (N1) 2.14 (1.42–3.24)
HIV knowledge (low/Did not know) –
History of imprisonment (yes) –
Inhaled cocaine use (ever) (yes) 1.90 (1.29–2.79)
Sexual violence (yes) –
⁎ Pb .05.
⁎⁎ Pb .01.
a PRR=prevalence rate ratio (weighted prevalence rate ratio).infection prevalence in both developed and developing countries [31].
A similar pattern has been observed among patients with mental
illness. Butterfield et al. [28], for example, studying racial differences
in hepatitis B (reactive anti-HBc) and associated risk behaviors in
American veterans with SMI, found a higher HBV prevalence (odds
ratio=1.47) among African Americans (27.6%), a group known to be
highly disadvantaged in the United States, as compared to Caucasians
(12.3%). A plausible explanation is a potential difference in baseline06–2007
Total anti-HBc
χ 2 (P-value) PRR (95% CI)a χ 2 (P-value)
21.90⁎⁎ 1.77 (1.55–2.01) 78.20⁎⁎
2.07 (1.70–2.53) 50.40⁎⁎
19.00⁎⁎ 1.0
– 1.52 (1.33–1.73) 38.90⁎⁎
– 1.17 (1.03–1.32) 6.14*
52.90⁎⁎ 1.35 (1.18–1.54) 20.10⁎⁎
– 1.24 (1.09–1.42) 22.70⁎⁎




– 1.24 (1.09–1.42) 10.10⁎⁎
– 1.37 (1.06–1.78) 5.63⁎
4.06⁎ – –
13.10⁎⁎ – –
– 1.18 (1.04–1.34) 6.23*
– 1.34 (1.19–1.51) 22.50⁎⁎
10.60⁎⁎ – –
– 1.45 (1.27–1.64) 32.50⁎⁎
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strated similar findings. For example, psychiatric patients with black
skin color and less than 5 years of schooling were significantly more
likely to have had past hepatitis B infection.
Unstable residence was correlated with both past and current HBV
infection. Although not independently associated with the outcomes
in this study, the finding of increased risks of current or past HBV
infection with a history of homelessness in the univariate analysis is
consistent with previous studies, which have indicated a significant
association between homelessness and HBV risk [10,32–34]. High risk
for HBV infection in the homeless population is due tomultiple factors
such as poverty, less social support, a larger number of people who
inject drugs, needle sharing, unprotected sex, unwanted sex and
survival sex and more frequent history of imprisonment [10,34–36].
History of imprisonment is of particular interest, as this charac-
teristic was independently associated with previous exposure to HBV
in our psychiatric patients, confirming studies showing that impris-
onment is an important predictor of HBV infection in patients with
mental illness [29,37]. Prison conditions increase the risk of
transmission of infections, including blood-borne viral infections.
This can be attributed to higher risky behaviors during incarceration
including sharing needles and razors and unsafe sex.
With respect to psychiatric characteristics, we found that HBV
infection was independently associated with any degree of intellec-
tual disability and a dementia diagnosis. Other studies have reported
a higher prevalence of HBV infection among people with intellectual
disabilities [38–41]. This association may be a result of factors related
to intellectual disability itself, institutionalization and specific
behaviors. These behaviors include taking objects into the mouth
and sharing food, small injuries inflicted by themselves or others,
dribbling or spitting, scratching and biting, self-mutilation, unhygie-
nic toilet habits, and bleeding lips and gums caused by antiepileptic
medication [40]. More frequent institutionalization is an important
factor influencing the risk for and frequency of HBV exposure [40].
Finally, poor HIV knowledge and low perception of HIV risk were
associated with HBV, although only the former remained in the final
model and with previous exposure only. Because HIV and HBV share
common modes of transmission, these variables are potential
markers for intervention points, especially in Brazil, where HIV and
hepatitis programs are within the same Department at the Ministry
of Health.
There are some limitations to the study. First, it is possible that the
prevalence of HBV infection in this population with mental illness
may be underestimated because the exclusion of CAPS-Ad (which
usually have a higher proportion of patients with substance use
disorder and/or injecting drug use) and because the heterogeneous
distribution of HBV by Brazilian Regions may not follow the AIDS
pattern. Second, because this is a cross-sectional study, direct causal
effect cannot be established. Finally, we were unable to assess the
actual phase of active HBV infection (acute or chronic), because we
did not use the anti-HBc-IgM serologic marker.
Nevertheless, the results reported in this national representative
study show that hepatitis B is an important comorbidity among
persons with mental illness in Brazil, with high prevalence of HBV
infection (previous and current infection). This particularly applies to
people with mental illness who are male, have black skin color, have
low education, suffer from intellectual impairment, have been
homeless or in prison, have experienced sexual violence, have
engaged in substance use during sex or had multiple sexual partners,
or have a history of cocaine use or an STD. Understanding these
sociodemographic and behaviorally related independent predictors of
HBV infection is important to the design of effective prevention and
intervention strategies. These would include systematic and universal
hepatitis B immunization of psychiatric patients; HBV serologic
screening; health education with preventive interventions that target
substance abuse and promote safer sex; reducing the incidence ofincarceration, psychiatric hospitalization and other forms of institu-
tionalization; achieving residential stability for people with mental
illness; and considering the feasibility of treatment for chronic active
HBV infection.Acknowledgments
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